Articles tagged with Cancer Patients
Researchers developed a non-invasive method to screen for kidney cancer by measuring protein biomarkers in urine, achieving over 95% accuracy. The findings suggest the potential for an easy-to-use screening test, similar to mammograms or colonoscopies, to identify patients with kidney cancer at early stages.
A study published in JAMA found significant discrepancies in diagnoses of atypia and DCIS, highlighting the need for women to seek second opinions. The study involved 115 pathologists and 6,900 breast biopsy interpretations, revealing a concordance rate of 75.3% for invasive carcinoma but only 48% for atypia.
A study by NCCS reveals a new attenuated-dose regimen of sunitinib improves patient quality of life and reduces treatment costs for Asian patients with metastatic renal cell carcinoma. The median overall survival rate increased to 27.4 months, reducing toxicities by 30% compared to the conventional dosing.
A new international study has found a small subset of patients with adrenal cancer respond significantly to the investigational drug linsitinib, paving the way for personalized treatment options. The researchers plan to analyze DNA collected from the study to identify possible markers for response.
Researchers at Georgetown University Medical Center have discovered a cellular pathway that controls organ size, which is also related to cancer cell behavior. High-density cells activated the 'Hippo' molecular pathway, while low-density cells did not engage with it, leading to differences in invasion and growth.
Two new studies present striking findings on depression's influence on cardiovascular health, with depressed patients facing nearly double the risk of dying from heart disease. Additionally, survivors of heart attacks are found to be at higher risk for certain cancers, including lung and bladder cancer.
A genetically engineered immunotoxin called DT2219 has shown safety and clinical effectiveness in a phase I trial for patients with relapsed/refractory B-cell malignancies. Two patients achieved durable objective responses, highlighting the potential of this new treatment approach.
The NCCN Clinical Practice Guidelines in Oncology provide evidence-based recommendations for smoking cessation in patients with cancer. Combining pharmacologic therapy and counseling is the most effective approach, leading to improved cancer treatment effectiveness and decreased recurrence.
Researchers identified germline TP53 gene mutations in 1.3% of patients with early-onset colorectal cancer, comparable to the proportion attributed to APC gene mutations. The findings highlight the need for clinicians to counsel patients undergoing TP53 testing as part of multigene risk assessment.
Patients treated at high-volume facilities for stage III non-small cell lung cancer (NSCLC) have longer overall survival when receiving definitive concurrent chemotherapy and radiation therapy. Studies show improved outcomes for patients treated at these centers, regardless of academic or community status.
Researchers discovered a molecular cause for parvovirus selectivity in cancer cells, revealing the PKCη/Rdx-driven phosphorylation of PDK1. This biomarker predicts therapy effectiveness and identifies cancer cells independent of growth factors.
A new study has identified a group of molecules in prostate-cancer cells that can help distinguish which patients should be treated with radiation therapy if rising PSA levels indicate tumor recurrence. MicroRNA patterns, including miR-4516 and miR-601, may predict patient response to radiation therapy.
A phase II study shows patients with high-risk low-grade gliomas have a 73% three-year overall survival rate when treated with radiation and temozolomide, compared to 54% for historical controls. The findings suggest combining chemotherapy with radiation is the best treatment for these rare tumors.
A family history of prostate cancer in first-degree relatives increases breast cancer risk by 14%, according to a study of 78,171 women. Women with both breast and prostate cancer histories face an almost 2-fold increase in breast cancer risk
Researchers at CWRU found that African-American cancer patients with depression often experience different symptoms than white patients, including irritability and social isolation. These findings suggest that culturally sensitive depression measures are needed to accurately diagnose and treat black cancer patients.
A phase 2 clinical trial found that sunitinib significantly improved progression-free survival in patients with advanced differentiated thyroid cancer. The study showed that 83% of patients benefited from treatment, with either tumor shrinkage or slowed disease progression.
Researchers found that fast food companies fail to promote healthy menu items in their kid's ads, while prioritizing toy premiums. Children recalled toys more than 70% of the time, but noticed food less than half of the time.
A new study identified older white males with advanced bladder cancer as a high-risk group for suicide. Researchers found that these patients have a higher suicide risk compared to those with other genitourinary cancers.
Researchers found that patients who received chemotherapy after bladder cancer surgery had improved overall survival rates compared to those who underwent surgery alone. The study analyzed over 5,600 patients and demonstrated a significant reduction in mortality risk.
A study published in JAMA Oncology found that 10% of CLL patients discontinued ibrutinib therapy due to disease progression. Patients who experienced Richter's transformation or progressive CLL had poorer outcomes and required alternative therapy quickly after discontinuation.
Researchers have identified two urinary biomarkers that can predict bladder cancer-specific survival and guide treatment. The study validated the biomarkers in over 400 clinical samples, showing they are independent predictors of cancer prognosis.
A study published in JAMA Oncology found that patients with advanced cancer perceived a higher level of compassion from physicians when presented with an optimistically framed message about future treatment options. The results suggest the need for extra support and care for delivering bad news while preserving hope.
Researchers deciphered the signaling pathways associated with immortal cells, which work in parallel to suppress terminal differentiation. The discovery enables the use of purified proteins to reduce contamination and accelerate clinical application.
Pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and neutropenia have decreased intensive care consultation rates and lower mortality. The study shows that timely antibiotic delivery can lead to significant reductions in hospitalization and fatalities among pediatric cancer patients.
Researchers from Dartmouth's Norris Cotton Cancer Center have discovered the Cherenkov Effect can be measured to improve radiation therapy. The study found that light emission correlates with dose, making it suitable for narrow beam stereotactic radiation therapy and surface dosimetry applications.
A new TGen study finds targeting stroma surrounding cancer cells can improve treatments and extend patient survival in pancreatic cancer patients. High levels of stroma correlate with poor patient survival, with median survival rates ranging from 9-24 months depending on hyaluronan and collagen levels.
A new study found that cancer patients' preferences for involving family members in treatment decisions differ significantly by ethnic background, marital status, sex, age, and insurance status. Non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to share decision-making with their families.
Patients with locally advanced kidney cancer did not experience improved outcomes from adjuvant treatment with sorafenib or sunitinib. The average disease recurrence period was similar between those receiving the drugs and those on placebo, suggesting that these treatments may not be beneficial for this patient group.
A study of 945 patients with intermediate-risk prostate cancer found nearly four-fold higher mortality risk within 15 years compared to low-risk patients. The analysis suggests that active surveillance may not be suitable for all intermediate-risk patients, emphasizing the need for personalized treatment approaches.
A study reveals that hematopoietic stem cells are vulnerable to DNA damage when rapidly dividing under stress conditions. This can lead to premature aging and increase the risk of cancer.
A study by Brigham and Women's Hospital researchers uses epigenomic maps to predict a cancer's cell type of origin, providing new insights into early cancer events. This discovery could help guide treatment decisions for patients with unknown primary sites, which pose significant challenges.
Researchers have found that mutations in the PTEN gene lead to reduced activity and stability of a critical protein, promoting genetic instability and disease. This discovery could pave the way for new treatments for patients with both autism and cancer.
A study found that TERT mRNA levels are highly predictive of aggressive bladder cancers, allowing doctors to recommend targeted treatments and improve patient outcomes. The study also suggests that telomerase reactivation is crucial for the progression of bladder cancers, highlighting a potential target for disease intervention.
Researchers at UT Southwestern Medical Center found that acetate supplements accelerate tumor growth and metastasis in mice. The study suggests that modulating acetate production could be a key to designing therapies for cancer patients.
A survey of 2500 Dutch doctors found that 86% would consider helping a patient to die under certain circumstances. Attitudes towards euthanasia and assisted suicide varied by condition, with most willing to help patients with cancer or other physical diseases, but fewer for those with mental illnesses.
Researchers discovered a key pathway driving tumour growth in bile duct cancer and found that blocking it can prevent cancer cell growth and shrink tumours. The treatment is already being tested in patients with other cancers and shows promise as a potential breakthrough for this devastating disease.
Researchers have identified a new biomarker that can help identify patients who are more likely to respond to certain chemotherapies. MAGE-A3/6 genes contribute to tumor growth by inhibiting AMPK, a protein that controls cellular energy levels and suppresses cancerous tumors.
The 44th annual Barrett-Jackson Scottsdale Auction raised $140,000 for TGen's colon and prostate cancer research. The event featured a '79 Cutlass sold by actress Sharon Stone, previously raising over $600,000 for TGen.
A new study of cancer patient-clinician encounters found that only a small percentage of patients requested clinically inappropriate tests or treatments. Most requests were for imaging studies, laboratory tests, or palliative care interventions, with few requesting chemotherapy or proton beam therapy.
Research presented at the American Stroke Association's International Stroke Conference 2015 found that stroke survivors have a higher annual rate of age-adjusted cancer incidence compared to the general population. Additionally, stroke survivors who develop cancer are more than three times likely to die compared to those without cancer.
Patients who preferred physician-controlled decisions had lower reported quality of care compared to those with shared decision-making. Patients' reports about the quality of their care are increasingly important health care performance measures.
Researchers at A*STAR's Genome Institute of Singapore have developed an expert system called OncoIMPACT that combines cancer omics data with machine learning models to predict treatment targets. The system has been applied to over a thousand cancers, including melanomas and ovarian cancers, and shows promise for personalized medicine.
Researchers found that certain HPV+ oropharyngeal cancer patients can survive for over two years without further disease after intensive treatment. The study identified key factors contributing to the survival advantage, including cancer sensitivity to radiotherapy and chemotherapy.
Researchers have developed a revolutionary model to study hematopoiesis in living organisms, revealing that at least one-third of blood stem cells produce differentiated progenitor cells. The study also shows that mature blood cells are supplied by first progenitor cells that regenerate themselves over time.
A new radiotracer has been developed to accurately identify the sentinel node in head and neck squamous cell carcinoma, reducing the need for extensive surgery. The study shows a high detection rate and low false negative rate for SNs, facilitating accurate prediction of cancer spread.
A study of 5,050 patient-clinician encounters found that only 1% were clinically inappropriate, and physicians complied with fewer than 1 in 10 requests. The findings challenge the myth of the 'demanding patient' and suggest a need to redirect attention from unnecessary costs.
New research suggests that cancer false alarms could lead to patients delaying symptom checks due to a lack of support. A systematic review found that over-reassurance and under-support can discourage patients from seeking help for new or recurrent symptoms.
A study found that young adult survivors (18-39) report higher distress levels than older survivors, despite similar time since treatment completion. Fear of cancer recurrence and financial burden were key predictors of elevated distress in these young adults.
Researchers found higher proportions of women and young adults dying of mesothelioma in two counties encompassing Las Vegas, suggesting naturally occurring mineral fibers are a contributing source. The study highlights the need for more research to reduce exposure.
A new $10 million research program aims to investigate and experimentally validate nutritional interventions, develop reliable DNA tests, and introduce new cancer prevention strategies to the general public and policymakers. Research suggests that more than half of all colon cancers can be prevented through dietary and behavioral inter...
Researchers at the University of Minnesota Academic Health Center have developed a new reporter system to study bone regeneration potential in human embryonic stem cells. The system allows for better monitoring of cell properties and may lead to the creation of new therapies for diseases such as leukemia or genetic blood disorders.
The center aims to provide clinical care and research using heavy particles for innovative new cancer treatments, offering a more potent and precise therapy than conventional options. The project is expected to create 130 high-level jobs and generate over $600 million in economic impact for Texas.
A recent study by UT Southwestern Medical Center found that patients with a prior cancer diagnosis have similar clinical outcomes to those without a history of cancer. The researchers studied over 102,000 patients and found that these patients had better overall survival and lung cancer-specific survival rates.
A new study from Columbia University Medical Center has found that a drug targeting the fused protein in glioblastoma may lead to significant clinical improvement and tumor reduction. The research suggests that developing a more precise drug could result in better treatment outcomes for patients with brain cancer.
A recent study found that nearly a third of women with N2/N3 breast cancer did not receive post-mastectomy radiation therapy (PMRT), which is the standard of care for this patient group. The study evaluated over 57,000 cases and found that socioeconomic factors did not influence PMRT receipt.
A new study has identified eight specific physical signs associated with imminent death in cancer patients, including non-reactive pupils and drooping of the nasolabial fold. These signs can help healthcare professionals make a diagnosis of impending death, allowing for more informed decisions about treatment and care.
A study by MD Anderson researchers identified eight physical and cognitive signs associated with imminent death in cancer patients. These signs include nonreactive pupils, decreased response to verbal and visual stimuli, and upper gastrointestinal bleeding, which could help clinicians communicate with patients and families, as well as ...
Researchers at NIH identified chromothripsis as the reason for a patient's spontaneous cure of WHIM syndrome. The study showed that a random deletion of mutant CXCR4 gene in stem cells led to normal neutrophil function.
Two-thirds of primary care health professionals want to widen exemption criteria for long-term conditions and lower or abolish charges altogether. The current system is seen as a barrier that prevents some people from receiving necessary prescriptions.
A new Special Issue from ecancermedicalscience tackles fertility-sparing cancer treatments, collecting latest research on preserving fertility in breast, cervical and ovarian cancers. Fertility-sparing treatments balance patient's wishes with oncological outcomes.